Can smarter technology selection help de-risk small-molecule development?

Summary

The article discusses how predictive modelling for drug formulation can help small-molecule developers select promising approaches and identify manufacturing challenges earlier, potentially de-risking development. No specific company announcements, trial data, or regulatory events are reported.